sefulness of serum HBV RNA as possible marker for HBV persistent infection and reactivatio
Not Applicable
Recruiting
- Conditions
- Chronic hepatitis B, Acute hepatitis B, HBV cirrhosis, HBV carrier, past history of HBV infection
- Registration Number
- JPRN-UMIN000038790
- Lead Sponsor
- Gastroenterology and Hepatology, Internal Medicine, School of Medicine, Keio University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who refuse to participate or who are deemed inappropriate to participate
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The correlation of serum HBV RNA with 1. Serum HBV DNA 2. Serum HBsAg 3. Serum HBcrAg at inclusion, before treatment, and 1-12 months after inclusion/ treatment
- Secondary Outcome Measures
Name Time Method 1. Serum AST, ALT 2. Liver residual function including serum bilirubin, albumin, PT activity 3. Liver fibrosis serological markers 4. Incidence of de novo or recurrent HCC